Biocom Ltd. began in 1978, with offices in New York City. Kenneth Youngstein, the founder and CEO, had previously worked for the New York Blood Center, first establishing their virus research laboratory in West Africa and then as Director of Development for the New York- New Jersey Regional Transplant Program, one of the world’s first organ banks. There, he began developing educational programs for professionals and patients, as well as strategic work in medical ethics and legal policy.
Biocom is a communications and education company working mostly with healthcare companies and non-profit and government agencies throughout the world. With the introduction of ACTS, in 1989, Biocom expanded its client focus and began working with banks, insurance and other financial service companies.
As most projects were on an international basis, in 1992, Biocom moved its offices to Zurich, Switzerland and became a Swiss corporation in 1999.
Today, Biocom is a leading innovator in the use of cutting edge technologies and behavioral psychology to expand the frontiers of training.